Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based studyArchived
Similar to other European countries, cervical infection with HPV-16, the HPV type with the strongest oncogenic potential, were most common both overall and among women with cervical disease.
Economic evaluation of human papilloma virus vaccination in the European Union: a critical reviewArchived
The authors performed a literature review of all economic evaluations (EEs) of HPV vaccines conducted in EU countries and published in English from January 2007 to June 2010. EEs were classified and compared according to their model, the economic variables used, the modelling techniques and whether or not they had financial backing from vaccine manufacturers.